Olympus Corp. · TSE:7733

Olympus — 44th J.P. Morgan Healthcare Conference (January 2026)

14 slides from Olympus's conference presentation, Jan 13, 2026

  1. Slide 1: Olympus Corporate Strategy: Where Purpose Meets Performance

    Olympus Corporate Strategy Where Purpose Meets Performance JP Morgan Conference January 13, 2026 INTERNAL USE ONLY

  2. Slide 2: Disclaimer

    Disclaimer  This material contains forward-looking statements that reflect management’s current views, plans, and expectations based on information available at the time of preparation. These forward-looking statements are not guarantees of future performance and involve known and unknown risks, unc

  3. Slide 3: Global Trends Show Increasing Demand for Endoscopy Procedures

    Global Trends Show Increasing Demand for Endoscopy Procedures, Underpinned by Macroeconomic Factors and the Need for Better Care Global demand drives 5% annual growth of endoscopy-enabled care 1 600M Potential global  Aging populations (>40% of the global population over 60) procedures3  Growing p

  4. Slide 4: Olympus is Best Positioned to Deliver on That Future

    Olympus is Best Positioned to Deliver on That Future for Patients, Clinicians and Administrators A Backbone of Advanced Endoscopes and Smart Technologies Scalable Endoscopy Therapeutic Devices Driving the Future Largest installed base of interoperable Broad portfolio of scopes and therapeutic AI, ro

  5. Slide 5: Envisioning the Future of Endoscopy-Enabled Care

    Envisioning the Future of Endoscopy-Enabled Care Better care Powered by an integrated ecosystem Detect diseases earlier Expanding minimally- Enabling more Driving safety Ecosystem of cloud connected Integrated data to Same day diagnosis, invasive therapeutic diseases to be and efficiencies hardware, d

  6. Slide 6: Where Purpose Meets Performance: Shaping the Future of Endoscopy-Enabled Care

    Where Purpose Meets Performance: Shaping the Future of Endoscopy-Enabled Care OUR PURPOSE Making people’s lives healthier, safer and more fulfilling OUR STRATEGIC PILLARS Innovation-Driven Growth Simplicity Accountability Lead the next wave of innovation & Simplify Olympus to Support a high-performan

  7. Slide 7: 3-4-5% Revenue Growth Plan

    3-4-5% Revenue Growth Plan ~1pp Growth YoY Innovation-Driven Growth  Fortify portfolio through focused investments  Shape the future of endoscopy through OLYSENSE and robotics  Enhance performance in China and set direction for emerging markets Potential growth  Drive M&A tuck-ins in close adjac

  8. Slide 8: Unlocking Growth through Portfolio Expansion and China Manufacturing

    Unlocking Growth through Portfolio Expansion and China Manufacturing URO GI-ET GI / RESP Local manufacturing in China MacroLux Medical single-use GORE VIABIL Biliary EU-ME3 Ultrasound Processor cystoscopes, ureteroscopes Endoprosthesis for endoscopic and suction access sheaths placement EDOF Scope V

  9. Slide 9: Shaping the Future of the Endosuite through AI and Robotics

    Shaping the Future of the Endosuite1 through AI and Robotics Introduced OLYSENSE CAD/AI - a suite of cloud-based, AI-powered Co-founded Swan EndoSurgical, developing a novel Endoluminal applications, marking the first step in the OLYSENSE intelligent Robotic system designed to revolutionize gastroint

  10. Slide 10: ~100 bps Margin Improvement YoY

    ~100 bps Margin Improvement YoY Short & mid-term Longer term Drivers Drivers Division-led operating model drives efficiency Improve business processes and build more resilient manufacturing and supply chain, driving COGS and SG&A towards industry benchmark ~2,000 ~24B JPY (~160M USD) 1. Business proce

  11. Slide 11: Capital Allocation to Drive Growth and Shareholder Value

    Capital Allocation to Drive Growth and Shareholder Value Prioritize Business  Investment for profitable, organic growth Investment  Strategic investment for growth opportunities Stable and gradual dividend increase in line with medium to long-term  Dividends Shareholder business performance Return

  12. Slide 12: Optimize Cash Flow and Fuel Corporate Venture Capital

    Optimize Cash Flow and Fuel Corporate Venture Capital Value Driven Capital Allocation Driving Olympus Innovation Ventures : Excellence in Free Cash Flow Conversion Powered by Financial Discipline  Strategic portfolio management: Allocate capital and USD resources to Olympus' key focus areas in high

  13. Slide 13: Quality Transformation Continues, as Business Momentum Builds

    Quality Transformation Continues, as Business Momentum Builds Tailwinds Headwinds & Active Management  Strong GI performance across Europe, APAC and significant  Elevated regulatory and quality oversight environment opportunities in the U.S.  External cost pressures, including tariffs  China’s mar

  14. Slide 14: Our Journey Has Already Started …

    Our Journey Has Already Started …

Olympus — 44th J.P. Morgan Healthcare Conference (January 2026) on 6ix